Showing results (891-900 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|March 25, 2021
Which novel agents will have a clinically meaningful impact in AML at diagnosis?Alexander E PerlBest Practice & Research. Clinical Haematology|December 6, 2021
Will immunotherapy lead to a breakthrough in the treatment of older adults with ALL?Ibrahim Aldoss, Anjali Advani, Vinod PullarkatBest Practice & Research. Clinical Haematology|December 6, 2021
Can venetoclax-based therapy replace 7+3 induction in fit older adults with AML?James M ForanBest Practice & Research. Clinical Haematology|December 6, 2021
Can molecular insights guide treatment of AML evolved from MPNs?John Crispino, Raajit RampalBest Practice & Research. Clinical Haematology|December 6, 2021
Is there an optimal adjunct therapy to traditional cytotoxic induction?Laura C MichaelisBest Practice & Research. Clinical Haematology|December 6, 2021
What is the role of the bone marrow microenvironment in AML?Nirupama Mulherkar, David T ScaddenBest Practice & Research. Clinical Haematology|December 6, 2021
Changing trends in the therapy of acute myeloid leukemiaJacob M RoweBest Practice & Research. Clinical Haematology|November 24, 2018
What biologic factors predict for transformation to AML?Rafael BejarBest Practice & Research. Clinical Haematology|November 24, 2018
Can one target T-cell ALL?Adolfo FerrandoBest Practice & Research. Clinical Haematology|November 24, 2018
Identifying patients with genetic predisposition to acute myeloid leukemiaEllyn Obrochta, Lucy A GodleyPageof 113